TY - JOUR
T1 - Predictive factors of biochemical recurrence after radical prostatectomy for high-risk prostate cancer
AU - Murata, Yukiko
AU - Tatsugami, Katsunori
AU - Yoshikawa, Masahiro
AU - Hamaguchi, Masumitsu
AU - Yamada, Shigetomo
AU - Hayakawa, Yusuke
AU - Ueda, Kouhei
AU - Momosaki, Seiya
AU - Sakamoto, Naotaka
N1 - Publisher Copyright:
© 2018 The Japanese Urological Association
PY - 2018/3
Y1 - 2018/3
N2 - Objective: To identify risk factors of biochemical recurrence after radical prostatectomy in high-risk patients. Methods: A total of 191 high-risk prostate cancer patients according to the D'Amico classification treated with radical prostatectomy at a single institution between April 2000 and December 2013 were enrolled. The pathological evaluation including intraductal carcinoma of prostate was reassessed, and the clinical and pathological risk factors of biochemical recurrence were analyzed. Results: The median follow up after radical prostatectomy was 49 months. The 5-year biochemical recurrence-free survival rate after radical prostatectomy in high-risk prostate cancer patients was 41.6%. Initial prostate-specific antigen, pathological Gleason score, seminal vesicle invasion, extraprostatic extension and intraductal carcinoma of the prostate were significantly associated with biochemical recurrence-free survival. The 5-year biochemical recurrence-free survival rates in patients with zero, one, two and three of these risk factors were 92.9%, 70.7%, 38.3% and 28.8%, respectively. In patients with four or more factors, the biochemical recurrence-free survival rate was 6.1% after 18 months. Conclusions: In D'Amico high-risk patients treated with radical prostatectomy, risk factors for biochemical recurrence can be identified. Patients with fewer risk factors have longer biochemical recurrence-free survival, even among these high-risk cases.
AB - Objective: To identify risk factors of biochemical recurrence after radical prostatectomy in high-risk patients. Methods: A total of 191 high-risk prostate cancer patients according to the D'Amico classification treated with radical prostatectomy at a single institution between April 2000 and December 2013 were enrolled. The pathological evaluation including intraductal carcinoma of prostate was reassessed, and the clinical and pathological risk factors of biochemical recurrence were analyzed. Results: The median follow up after radical prostatectomy was 49 months. The 5-year biochemical recurrence-free survival rate after radical prostatectomy in high-risk prostate cancer patients was 41.6%. Initial prostate-specific antigen, pathological Gleason score, seminal vesicle invasion, extraprostatic extension and intraductal carcinoma of the prostate were significantly associated with biochemical recurrence-free survival. The 5-year biochemical recurrence-free survival rates in patients with zero, one, two and three of these risk factors were 92.9%, 70.7%, 38.3% and 28.8%, respectively. In patients with four or more factors, the biochemical recurrence-free survival rate was 6.1% after 18 months. Conclusions: In D'Amico high-risk patients treated with radical prostatectomy, risk factors for biochemical recurrence can be identified. Patients with fewer risk factors have longer biochemical recurrence-free survival, even among these high-risk cases.
UR - http://www.scopus.com/inward/record.url?scp=85044255956&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85044255956&partnerID=8YFLogxK
U2 - 10.1111/iju.13514
DO - 10.1111/iju.13514
M3 - Article
C2 - 29315854
AN - SCOPUS:85044255956
SN - 0919-8172
VL - 25
SP - 284
EP - 289
JO - International Journal of Urology
JF - International Journal of Urology
IS - 3
ER -